CAMP4 Therapeutics Corporation Common Stock (CAMP) is a publicly traded Healthcare sector company. As of July 27, 2026, CAMP trades at $3.32 with a market cap of $164.09M and a P/E ratio of -1.34. CAMP moved +5.06% today. Year to date, CAMP is -46.35%; over the trailing twelve months it is +64.58%. Its 52-week range spans $1.31 to $10.80. Analyst consensus is strong buy with an average price target of $8.50. Rallies surfaces CAMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CAMP shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.32 |
| Market Cap | $164.09M |
| P/E Ratio | -1.34 |
| EPS | $-2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.80 |
| 52-Week Low | $1.31 |
| Volume | 9.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.93M |
| Net Income | $-86.30M |
| Gross Margin | 0.00% |
6 analysts cover CAMP: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.50.